| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2020 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| iShares iBonds Dec 2023 Term Tr ETF | 1 | Q3 2023 | 27.9% |
| Vanguard High Dividend Yield Index ETF | 1 | Q3 2023 | 3.5% |
| Vanguard FTSE Developed Markets ETF | 1 | Q3 2023 | 3.4% |
| iShares Core S&P Small-Cap | 1 | Q3 2023 | 2.6% |
| SPDR Bloomberg Barclays 1-3 Mo T-Bill ETF | 1 | Q3 2023 | 2.4% |
| Microsoft Corp | 1 | Q3 2023 | 2.3% |
| Vanguard Dividend Appreciation ETF | 1 | Q3 2023 | 2.0% |
| iShares Core MSCI EAFE | 1 | Q3 2023 | 1.6% |
| Procter & Gamble Co | 1 | Q3 2023 | 1.3% |
| International Flavors & Fragrances | 1 | Q3 2023 | 1.3% |
View Arlington Trust Co LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-16 |
| 13F-HR | 2024-01-24 |
| 13F-HR | 2023-10-24 |
View Arlington Trust Co LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.